Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7386 p125
4 February 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Prescription charge overhaul for Scotland likely

Exemption categories for NHS prescription charges in Scotland are to be overhauled after consultation, although charges will remain in place.

This seems the most likely outcome now that a Bill that aimed to abolish prescription charges was defeated in the Scottish Parliament last week. On the same day, the Scottish Executive announced the start of a three-month consultation on prescription charge exemption categories (see Panel).

Consultation on possible reforms

Views are being sought by the Scottish Executive on a number of issues:

· On chronic conditions, it asks whether exemptions should continue to be given on medical grounds alone and, if so, whether the list of conditions needs amending. Another possibility is allowing the exemption to cover drugs related to the exempt condition, only, and not to all prescriptions for the patient. Alternatively, exemptions could be based on a list of drugs rather than a list of conditions.

· Possible changes to exemptions based on age include extending the student exemption to include those in tertiary education.

· Exemptions based on income are also discussed, along with pre-payment certificates. Suggested reforms include issuing retrospective pre-payment certificates once a certain number of charges have been paid, introducing a form of capping to the total charge that can be paid, or introducing a concessionary rate for patients requiring regular prescriptions.

· Another potential approach is introducing a lower flat fee that is payable by everyone except those exempt by age or low income.

Responses should be e-mailed to prescriptioncharges@scotland.gsi.gov.uk by 30 April. The consultation document can be accessed here

The Bill, which was put forward by Colin Fox MSP, was defeated by 77 votes to 40, with one abstention. The vote followed a heated debate in which health minister Andy Kerr said the Bill would rob the poor to give to the rich by diverting NHS resources from hospitals and staffing into free prescriptions for all.

“The alternative is set out in our consultation,” he said. “It will consider whether exemptions for people on low incomes might be extended, how the medical exemption arrangements might be reformed to be fairer for all, whether exemptions should be extended to people in full-time education and training, and whether payment arrangements for high users should be reformed.” But Mr Fox hit back, saying that the Executive showed disdain for the Parliament by waiting until just three hours before the debate to announce the consultation when the Bill had been before Parliament for two years. Despite gaining support for this protest, the Bill was defeated.

Back to Top


©The Pharmaceutical Journal